Oric Pharmaceuticals, Inc. ORIC Financing Cash Flow
Financing Cash Flow at other companies
Other financials
Where this comes from
Reported directly by Oric Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInFinancingActivities.
The official record: Oric Pharmaceuticals, Inc.’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →
Ask your AI about Oric Pharmaceuticals, Inc.'s financing cash flow.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Oric Pharmaceuticals, Inc.'s financing cash flow?
- Oric Pharmaceuticals, Inc. (ORIC) reported financing cash flow of $61.14M in Q1 2026.
- How has Oric Pharmaceuticals, Inc.'s financing cash flow changed year-over-year?
- Oric Pharmaceuticals, Inc.'s financing cash flow increased by 555718.2% year-over-year, from $11K to $61.14M.
- What is the long-term trend for Oric Pharmaceuticals, Inc.'s financing cash flow?
- Over 4 years (2021 to 2025), Oric Pharmaceuticals, Inc.'s financing cash flow has grown at a 49.5% compound annual growth rate (CAGR), from $49.13M to $245.26M.
- What does financing cash flow mean?
- Total net cash provided by or used in financing activities — debt issuance/repayment, equity transactions, and dividend payments.